04/24/2025
7:59 AM | BlackRock, Inc. (Filed by)
Rhythm Pharmaceuticals (Subject)
| Form SCHEDULE 13G/A | |
04/16/2025
3:30 PM | Mazabraud Yann (Reporting)
Rhythm Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/10/2025
4:16 PM | Mazabraud Yann (Reporting)
Rhythm Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/10/2025
4:17 PM | Cramer Pamela J. (Reporting)
Rhythm Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/07/2025
6:01 AM | Rhythm Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/24/2025
4:47 PM | German Christopher Paul (Reporting)
Rhythm Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/20/2025
3:05 PM | Rhythm Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/18/2025
8:16 PM | Mazabraud Yann (Reporting)
Rhythm Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/14/2025
3:21 PM | Mazabraud Yann (Reporting)
Rhythm Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/28/2025
7:19 AM | Rhythm Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/28/2025
7:21 AM | Rhythm Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Get the Latest News and Ratings for RYTM and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Rhythm Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. |
02/26/2025
6:02 AM | Rhythm Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/19/2025
8:45 PM | German Christopher Paul (Reporting)
Rhythm Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/19/2025
8:46 PM | Lee Jennifer Kayden (Reporting)
Rhythm Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/19/2025
8:47 PM | Mazabraud Yann (Reporting)
Rhythm Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/19/2025
8:48 PM | Meeker David P (Reporting)
Rhythm Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/19/2025
8:49 PM | Rhythm Pharmaceuticals (Issuer)
Shulman Joseph (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/19/2025
8:50 PM | Rhythm Pharmaceuticals (Issuer)
Smith Hunter C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/19/2025
8:44 PM | Garfield Alastair (Reporting)
Rhythm Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/19/2025
8:43 PM | Cramer Pamela J. (Reporting)
Rhythm Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/13/2025
5:36 PM | PRIMECAP MANAGEMENT CO/CA/ (Filed by)
Rhythm Pharmaceuticals (Subject)
| Form SCHEDULE 13G/A | |
02/11/2025
8:46 PM | Lee Jennifer Kayden (Reporting)
Rhythm Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/11/2025
8:47 PM | Rhythm Pharmaceuticals (Issuer)
Shulman Joseph (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/11/2025
8:44 PM | Rhythm Pharmaceuticals (Issuer)
Smith Hunter C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/11/2025
8:45 PM | Cramer Pamela J. (Reporting)
Rhythm Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/10/2025
4:30 PM | GOLDMAN SACHS GROUP INC (Filed by)
GOLDMAN SACHS GROUP INC (Filed by)
Rhythm Pharmaceuticals (Subject)
| Form SCHEDULE 13G/A | |
02/07/2025
4:05 PM | Lee Jennifer Kayden (Reporting)
Rhythm Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2025
3:20 PM | Lee Jennifer Kayden (Reporting)
Rhythm Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/04/2025
8:27 PM | Rhythm Pharmaceuticals (Issuer)
Smith Hunter C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/04/2025
8:22 PM | Cramer Pamela J. (Reporting)
Rhythm Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/04/2025
8:23 PM | Lee Jennifer Kayden (Reporting)
Rhythm Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/04/2025
8:25 PM | Meeker David P (Reporting)
Rhythm Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/04/2025
8:26 PM | Rhythm Pharmaceuticals (Issuer)
Shulman Joseph (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/10/2025
6:17 AM | Rhythm Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/14/2024
8:50 PM | PERCEPTIVE ADVISORS LLC (Filed by)
Rhythm Pharmaceuticals (Subject)
| Form SC 13G | |
11/14/2024
4:46 PM | RA CAPITAL MANAGEMENT, L.P. (Filed by)
Rhythm Pharmaceuticals (Subject)
| Form SC 13G/A | |
11/13/2024
8:01 PM | Rhythm Pharmaceuticals (Issuer)
Shulman Joseph (Reporting)
| Form 4/A | |
11/13/2024
8:02 PM | Rhythm Pharmaceuticals (Issuer)
Shulman Joseph (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/13/2024
8:04 PM | Lee Jennifer Kayden (Reporting)
Rhythm Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/06/2024
4:07 PM | Cramer Pamela J. (Reporting)
Rhythm Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/06/2024
7:20 AM | Rhythm Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
Musk's warning signal: Prepare before the cascade begins (Ad) When Elon Musk triggered his AI layoff plan, most analysts missed what it really meant. Louis Navellier didn’t.
With 40+ years of market modeling, he says Musk’s move wasn’t about efficiency — it was a signal. And what’s coming next could divide the market into winners and losers faster than anyone expects. Watch this urgent video briefing now. Watch the Musk market warning before the dominoes fall |
11/05/2024
3:02 PM | Rhythm Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/19/2024
3:49 PM | Rhythm Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/19/2024
3:30 PM | GOOD JENNIFER L (Reporting)
Rhythm Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/17/2024
3:42 PM | GOOD JENNIFER L (Reporting)
Rhythm Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/11/2024
3:30 PM | GOOD JENNIFER L (Reporting)
Rhythm Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/11/2024
3:31 PM | Rhythm Pharmaceuticals (Issuer)
TETRAULT LYNN A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/11/2024
3:32 PM | Cramer Pamela J. (Reporting)
Rhythm Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/09/2024
3:31 PM | GOOD JENNIFER L (Reporting)
Rhythm Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/28/2024
3:30 PM | GOOD JENNIFER L (Reporting)
Rhythm Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/28/2024
3:31 PM | Rhythm Pharmaceuticals (Issuer)
TETRAULT LYNN A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/28/2024
3:31 PM | Cramer Pamela J. (Reporting)
Rhythm Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/26/2024
3:26 PM | Cramer Pamela J. (Reporting)
Rhythm Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/26/2024
3:27 PM | Rhythm Pharmaceuticals (Subject)
TETRAULT LYNN A. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/26/2024
3:27 PM | GOOD JENNIFER L (Reporting)
Rhythm Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/13/2024
3:45 PM | Cramer Pamela J. (Reporting)
Rhythm Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/12/2024
3:13 PM | Rhythm Pharmaceuticals (Subject)
TETRAULT LYNN A. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/07/2024
5:00 AM | Rhythm Pharmaceuticals (Filer)
| Form DEFR14A | |
08/07/2024
5:03 AM | Rhythm Pharmaceuticals (Filer)
| Form DEFA14A | |
08/06/2024
6:00 AM | Rhythm Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/30/2024
4:09 PM | Cramer Pamela J. (Reporting)
Rhythm Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/18/2024
4:59 PM | Rhythm Pharmaceuticals (Issuer)
Shulman Joseph (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/16/2024
3:30 PM | Rhythm Pharmaceuticals (Issuer)
Shulman Joseph (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/16/2024
3:37 PM | Rhythm Pharmaceuticals (Subject)
Shulman Joseph (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/12/2024
3:34 PM | Rhythm Pharmaceuticals (Subject)
Shulman Joseph (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/10/2024
4:00 PM | Garfield Alastair (Reporting)
Rhythm Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
07/10/2024
4:01 PM | Garfield Alastair (Reporting)
Rhythm Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/10/2024
3:05 PM | Rhythm Pharmaceuticals (Filer)
| Form 424B7 | |
07/10/2024
3:07 PM | Rhythm Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/25/2024
3:39 PM | MCGIRR DAVID W J (Reporting)
Rhythm Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/25/2024
3:41 PM | Arbuckle Stuart A (Reporting)
Rhythm Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/25/2024
3:30 PM | GOOD JENNIFER L (Reporting)
Rhythm Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/25/2024
3:35 PM | JEAN CHRISTOPHE (Reporting)
Rhythm Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/25/2024
3:37 PM | Bedrosian Camille L (Reporting)
Rhythm Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/25/2024
3:38 PM | Mathers Edward T (Reporting)
Rhythm Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/25/2024
3:38 PM | Rhythm Pharmaceuticals (Issuer)
TETRAULT LYNN A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2024
8:44 PM | MCGIRR DAVID W J (Reporting)
Rhythm Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2024
8:47 PM | Rhythm Pharmaceuticals (Issuer)
TETRAULT LYNN A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2024
8:38 PM | Arbuckle Stuart A (Reporting)
Rhythm Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2024
8:39 PM | GOOD JENNIFER L (Reporting)
Rhythm Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2024
8:41 PM | Bedrosian Camille L (Reporting)
Rhythm Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2024
8:42 PM | JEAN CHRISTOPHE (Reporting)
Rhythm Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2024
8:43 PM | Mathers Edward T (Reporting)
Rhythm Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/17/2024
4:28 PM | Rhythm Pharmaceuticals (Filer)
| Form DEFA14A | |
06/17/2024
4:19 PM | Rhythm Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/07/2024
3:43 PM | Rhythm Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/07/2024
6:10 AM | Rhythm Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/30/2024
6:31 PM | NEW ENTERPRISE ASSOCIATES 13 LP (Filed by)
Rhythm Pharmaceuticals (Subject)
| Form SC 13D/A | |
Buy RYTM Stock Free RYTM Stock Alerts